Skip to main content
Premium Trial:

Request an Annual Quote

Structural Genomics Consortium Accesses OriGene cDNA Clone Collection

NEW YORK, Aug. 10 (GenomeWeb News) - OriGene Technologies said today that the Structural Genomics Consortium has accessed the company's TrueClone collection of over 22,000 non-redundant full-length human cDNA clones for use in its structural genomics program.


The SGC is a not-for-profit organization funded by the Wellcome Trust, GlaxoSmithKline, Genome Canada, the Ontario Research and Development Challenge Fund, the Ontario Innovation Trust, and the Canadian Institutes of Health Research. The initiative was launched in April 2003 with the goal of developing the infrastructure and technologies necessary to determine 200 protein structures per year. The SGC said it will target 350 medically significant proteins over the first four years.


"The SGC has acquired access to the OriGene collection to more rapidly extend capabilities of creating high quality protein samples for crystallization and structure determination, Michael Sundstrom, chief scientist for the SGC, said in a statement. "Access to clones from the OriGene collection combined with other sources will allow us to target the majority of genes in the first phase."


The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.